# Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma

> **NCT02245997** · EARLY_PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 78 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **RADIATION:** External beam radiotherapy
- **RADIATION:** proton beam RT

## Key facts

- **NCT ID:** NCT02245997
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02245997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02245997, "Local Control With Reduced-dose Radiotherapy for High-Risk Neuroblastoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02245997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*